DK47089A - Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer - Google Patents

Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer

Info

Publication number
DK47089A
DK47089A DK047089A DK47089A DK47089A DK 47089 A DK47089 A DK 47089A DK 047089 A DK047089 A DK 047089A DK 47089 A DK47089 A DK 47089A DK 47089 A DK47089 A DK 47089A
Authority
DK
Denmark
Prior art keywords
cancer
timal
tumors
procedures
agents
Prior art date
Application number
DK047089A
Other languages
English (en)
Other versions
DK47089D0 (da
Inventor
Karl Groke
Hans Miggitsch
Horst Musil
Josef Polzer
Original Assignee
Leopold & Co Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leopold & Co Chem Pharm filed Critical Leopold & Co Chem Pharm
Publication of DK47089D0 publication Critical patent/DK47089D0/da
Publication of DK47089A publication Critical patent/DK47089A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK047089A 1988-02-03 1989-02-02 Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer DK47089A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT218/88A AT393221B (de) 1988-02-03 1988-02-03 Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken

Publications (2)

Publication Number Publication Date
DK47089D0 DK47089D0 (da) 1989-02-02
DK47089A true DK47089A (da) 1989-09-15

Family

ID=3484658

Family Applications (1)

Application Number Title Priority Date Filing Date
DK047089A DK47089A (da) 1988-02-03 1989-02-02 Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer

Country Status (7)

Country Link
US (1) US5006551A (da)
EP (1) EP0326826B1 (da)
JP (1) JPH01226810A (da)
AT (2) AT393221B (da)
DE (1) DE58901002D1 (da)
DK (1) DK47089A (da)
ES (1) ES2033021T3 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03165602A (ja) * 1989-11-24 1991-07-17 Murata Mfg Co Ltd 誘電体共振器
HU207800B (en) * 1990-05-10 1993-06-28 Andras Sikter Process for producing composition for improving condition and for treating different illnesses
EP0668769B1 (en) * 1992-11-06 2000-04-19 Greystone Medical Group, Inc. Synthetic compositions related to oak bark extrakt, and method of using same
US5629327A (en) * 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
GB9306741D0 (en) * 1993-03-31 1993-05-26 Biocure Ltd Compounds
US6209259B1 (en) * 1997-07-11 2001-04-03 Encap, Llc Seeding treatments
EP1282416A2 (en) * 2000-05-19 2003-02-12 Progenics Pharmaceuticals, Inc. Dehydroascorbic acid formulations and uses thereof
AT411730B (de) * 2002-05-17 2004-05-25 Groke Karl Dr Mittel zur raucher-entwöhnung oder zur alkohol-entwöhnung
SE0201880D0 (sv) * 2002-06-19 2002-06-19 Milenca Gardovic Komposition för att behandla hudåkommor och för att förbättra hårtillväxt
AT412447B (de) * 2002-11-27 2005-03-25 C Y L Handelsges M B H Mittel mit zerstörender wirkung auf maligne tumore sowie verfahren zu seiner herstellung
US20050124684A1 (en) * 2003-08-29 2005-06-09 Ying Du 5-(hydroxymethyl) furfural and derivatives as inhibitors of TNFalpha and IL-1beta production
ES2510690T3 (es) 2004-12-17 2014-10-21 Alan B. Cash Método para extender la esperanza de vida y retrasar la aparición de enfermedad relacionada con la edad
US20110105617A1 (en) * 2005-01-11 2011-05-05 Sgp & Sons Ab Method for treatment of neoplastic diseases with alpha-keto glutarate and/or salts thereof
PL372183A1 (pl) 2005-01-11 2006-07-24 Sgp & Sons Ab Preparat przeciwnowotworowy oraz zastosowanie preparatu przeciwnowotworowego
AT503385B1 (de) * 2006-03-20 2008-05-15 C Y L Pharmazeutika Gmbh Mittel zur behandlung von oxidativem stress
DE102007007629A1 (de) 2007-02-16 2008-08-21 Evonik Degussa Gmbh Verfahren zur Herstellung von 5-Hydroxymethyl-furfural über 5-Acyloxymethyl-furfural als Zwischenprodukt
EP2255623A1 (en) * 2009-05-26 2010-12-01 Volker Wagner-Solbach Plant nutriments
CA2925546C (en) 2012-10-29 2022-06-14 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders
DE102013106530A1 (de) * 2013-06-21 2014-12-24 Christoph Pallua Krebsmedikament

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1125675A (en) * 1966-02-10 1968-08-28 Kyowa Hakko Kogyo Kk Stable ascorbic acid composition and process for preparing the same
JPS52108027A (en) * 1976-03-09 1977-09-10 Rikagaku Kenkyusho Anticarcinogen
JPS5412312A (en) * 1977-06-30 1979-01-30 Otsuka Chem Co Ltd Preparation of ketazine
JPS5470428A (en) * 1977-11-11 1979-06-06 Rikagaku Kenkyusho Carcinostatic agent
JPS54126731A (en) * 1978-03-20 1979-10-02 Rikagaku Kenkyusho Carcinostatic agent
JPS579712A (en) * 1980-06-20 1982-01-19 Fukumi Morishige Instilling (dripping) liquid for intravenous injection
DE3168925D1 (en) * 1980-12-23 1985-03-28 Koehler Chemie Dr Franz Protective solution for heart and kidney, and manufacturing process
WO1983002464A1 (en) * 1982-01-04 1983-07-21 Seymour, Robert, Stephen Diameter control in czochralski crystal growth
DE3686022D1 (de) * 1985-10-22 1992-08-20 Silvetti Sen Monosaccharide enthaltende zusammensetzung zum heilen von wunden.

Also Published As

Publication number Publication date
ATA21888A (de) 1991-02-15
DE58901002D1 (de) 1992-04-30
AT393221B (de) 1991-09-10
US5006551A (en) 1991-04-09
EP0326826A1 (de) 1989-08-09
ES2033021T3 (es) 1996-07-16
EP0326826B1 (de) 1992-03-25
JPH01226810A (ja) 1989-09-11
DK47089D0 (da) 1989-02-02
ATE74006T1 (de) 1992-04-15

Similar Documents

Publication Publication Date Title
DK47089A (da) Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
IS3156A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
DK0502092T3 (da) Oralt præparat til behandling af inflammatoriske tarmsygdomme
ATE209908T1 (de) RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN
SE8402550D0 (sv) N-substituerade deriavat av moranolin
JPS5756427A (en) Medicine containing 2-phenyl-1,2-benzisoselenazole- 3(2h)-one
SE8000435L (sv) N-bensylimidazoler med selektivt inhiberande verkan pa tromboxansyntetasenzymet jemte farmaceutiska beredningar innehallande sadana n-bensylimidazoler och sett for deras framstellning
EA200100127A1 (ru) Производные фенилксантина
DE69426334D1 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
RU94022017A (ru) Способ лечения акне или псевдофолликулита бороды, способ получения композиции, применение ингибитора фермента орнитиндекарбоксилазы для лечения акне или псевдофолликулита бороды
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
KR910005858A (ko) 지방산 요법
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
NO162283C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk,aktive substituerte 3-fenoksy-1-alkoksykarbonyl-alkylamino-propanoler-2.
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
FI801228A (fi) 6-substituerade 11-alkylen-morfantridiner foerfaranden foer deras framstaellning och terapeutiska medel innehaollande dessa
DK418986A (da) Pyrrolobenzimidazoler, pyrrolobenzoxazoler og pyrrolobenzthiazoler, fremgangsmaader til fremstilling heraf og laegemidler med indhold heraf
NO156900B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater.
KR890000108A (ko) 종양 치료용 약제학적 조성물
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DE69814691D1 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment